Skip to main content
SpringerLink
Log in

NICE recommends Eylea and Ozurdex for macular oedema

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • The National Institute for Health and Care Excellence. NICE gives green light to two eye treatments for treating serious eye condition. Media Release : 21 Jul 2015. Available from: URL: http://www.nice.org.uk

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

NICE recommends Eylea and Ozurdex for macular oedema. PharmacoEcon Outcomes News 733, 34 (2015). https://doi.org/10.1007/s40274-015-2335-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-2335-z

Search

Navigation